Acro Biomedical Co annual gross profit
2017
2018
2019
2019
2020
2021
2022
2023
Acro Biomedical Co Gross Profit Growth & History (ACBM)
Acro Biomedical Co's gross profit was $0 for fiscal 2023.
View full Acro Biomedical Co company overviewAcro Biomedical Co annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $0 | −$140,500 | — |
| 2022 | 2022-12-31 | $140,500 | −$119,000 | −45.86% |
| 2021 | 2021-12-31 | $259,500 | $100,096 | +62.79% |
| 2020 | 2020-12-31 | $159,404 | $147,308 | +1217.82% |
| 2019 · Dec 31 | 2019-12-31 | $12,096 | — | — |
| 2019 · Sep 30 | 2019-09-30 | $135,400 | −$698,000 | −83.75% |
| 2018 | 2018-09-30 | $833,400 | $782,400 | +1534.12% |
| 2017 | 2017-09-30 | $51,000 | — | — |
Acro Biomedical Co quarterly gross profit
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.25
Q3.25
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q1 2025 | 2025-03-31 | $0 | — | — |
| Q4 2023 | 2023-12-31 | $0 | −$64,000 | — |
| Q3 2023 | 2023-09-30 | $0 | $0 | — |
| Q2 2023 | 2023-06-30 | $0 | $0 | — |
| Q1 2023 | 2023-03-31 | $0 | −$76,500 | — |
| Q4 2022 | 2022-12-31 | $64,000 | −$86,000 | −57.33% |
| Q3 2022 | 2022-09-30 | $0 | $0 | — |
| Q2 2022 | 2022-06-30 | $0 | −$80,000 | — |
| Q1 2022 | 2022-03-31 | $76,500 | $47,000 | +159.32% |
| Q4 2021 | 2021-12-31 | $150,000 | $150,000 | — |
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q2 2021 | 2021-06-30 | $80,000 | $80,000 | — |
| Q1 2021 | 2021-03-31 | $29,500 | −$129,904 | −81.49% |
| Q4 2020 | 2020-12-31 | $0 | −$12,096 | — |
| Q3 2020 | 2020-09-30 | $0 | $0 | — |
| Q2 2020 | 2020-06-30 | $0 | $0 | — |
| Q1 2020 | 2020-03-31 | $159,404 | $159,404 | — |
| Q4 2019 · Dec 31 | 2019-12-31 | $12,096 | −$123,304 | −91.07% |
| Q4 2019 | 2019-09-30 | $0 | −$252,600 | — |
| Q3 2019 | 2019-06-30 | $0 | −$239,900 | — |
| Q2 2019 | 2019-03-31 | $0 | −$196,400 | — |
| Q1 2019 | 2018-12-31 | $135,400 | −$9,100 | −6.30% |
| Q4 2018 | 2018-09-30 | $252,600 | — | — |
| Q3 2018 | 2018-06-30 | $239,900 | — | — |
| Q2 2018 | 2018-03-31 | $196,400 | — | — |
| Q1 2018 | 2017-12-31 | $144,500 | — | — |
Acro Biomedical Co gross profit trends
Between the periods ended 2017-09-30 and 2023-12-31, Acro Biomedical Co's gross profit decreased from $51,000 to $0, a change of −$51,000. The latest reported quarter, Q3 2025, shows $0.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acro Biomedical Co source filings ↗